Chemie Grünenthal
E852354
Chemie Grünenthal is a German pharmaceutical company historically known for developing the drug thalidomide, which caused a major global medical scandal due to its severe birth defect side effects.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Chemie Grünenthal canonical | 1 |
| Grünenthal GmbH | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T10292186 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Chemie Grünenthal Context triple: [thalidomide, developedBy, Chemie Grünenthal]
-
A.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
B.
Bayer
Bayer is a major German multinational pharmaceutical and life sciences company known for products such as aspirin and its work in healthcare and agriculture.
-
C.
Ciba-Geigy
Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
-
D.
Schueller
Schueller is a French surname most notably associated with Eugène Schueller, the chemist and entrepreneur who founded the cosmetics company L’Oréal.
-
E.
Sandoz
Sandoz is a historic Swiss pharmaceutical company best known as a predecessor of Novartis and a major player in generic medicines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Chemie Grünenthal Target entity description: Chemie Grünenthal is a German pharmaceutical company historically known for developing the drug thalidomide, which caused a major global medical scandal due to its severe birth defect side effects.
-
A.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
B.
Bayer
Bayer is a major German multinational pharmaceutical and life sciences company known for products such as aspirin and its work in healthcare and agriculture.
-
C.
Ciba-Geigy
Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
-
D.
Schueller
Schueller is a French surname most notably associated with Eugène Schueller, the chemist and entrepreneur who founded the cosmetics company L’Oréal.
-
E.
Sandoz
Sandoz is a historic Swiss pharmaceutical company best known as a predecessor of Novartis and a major player in generic medicines.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
German company
ⓘ
pharmaceutical company ⓘ |
| apologizedFor | role in thalidomide tragedy ⓘ |
| associatedWithSideEffect |
phocomelia
ⓘ
severe birth defects ⓘ |
| country | Germany ⓘ |
| developed | thalidomide ⓘ |
| engagesIn |
clinical trials
ⓘ
pharmaceutical research and development ⓘ |
| focusesOn |
pain management
ⓘ
rare diseases ⓘ |
| foundedBy | Hermann Wirtz ⓘ |
| hasCorporateForm |
GmbH
ⓘ
linked to:
Gesellschaft mit beschränkter Haftung
|
| hasEthicalIssue | drug safety oversight failures related to thalidomide ⓘ |
| hasReputation | controversial due to thalidomide ⓘ |
| hasSubsidiary |
Grünenthal GmbH
ⓘ
linked to:
Chemie Grünenthal
|
| headquartersLocation |
Germany
ⓘ
North Rhine-Westphalia ⓘ Stolberg ⓘ |
| implements | pharmacovigilance systems ⓘ |
| industry |
biotechnology
ⓘ
pharmaceutical industry ⓘ |
| involvedIn |
global drug safety controversy
ⓘ
thalidomide scandal ⓘ |
| languageOfOperation |
English
ⓘ
German ⓘ |
| legalStatus | faced lawsuits related to thalidomide ⓘ |
| marketedAs |
sedative
ⓘ
treatment for morning sickness in pregnancy ⓘ |
| notableFor | development of thalidomide ⓘ |
| operatesIn |
Asia-Pacific
ⓘ
Europe ⓘ Latin America ⓘ |
| participatesIn | global pharmaceutical markets ⓘ |
| productType |
analgesics
ⓘ
central nervous system drugs ⓘ dermatology drugs ⓘ oncology drugs ⓘ opioid analgesics ⓘ respiratory drugs ⓘ women's health drugs ⓘ |
| regulatoryInteraction |
European medicines authorities
ⓘ
linked to:
European medicines regulatory authorities
German drug regulators ⓘ |
| roleInEvent | manufacturer of thalidomide ⓘ |
| subjectOf |
historical studies of the thalidomide disaster
ⓘ
public health debates on drug safety ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Chemie Grünenthal Description of subject: Chemie Grünenthal is a German pharmaceutical company historically known for developing the drug thalidomide, which caused a major global medical scandal due to its severe birth defect side effects.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
linked to: Chemie Grünenthal